Loading clinical trials...
Loading clinical trials...
Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Conditions
Interventions
nab-Paclitaxel
Gemcitabine
Locations
14
United States
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
A.I. duPont Hospital for Children, Delaware - Nemours
Wilmington, Delaware, United States
Shand's Hospital for Children at the University of Florida
Gainesville, Florida, United States
Nemours Children's Clinic
Jacksonville, Florida, United States
Start Date
October 25, 2016
Primary Completion Date
November 19, 2024
Completion Date
February 17, 2025
Last Updated
April 2, 2026
NCT06721689
NCT04308330
NCT06541262
NCT07479732
NCT03715933
NCT07144254
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions